ArticleFrontiers in immunology2026
Subclinical inflammation associated with monosodium urate crystal deposition: a cellular and proteomic study in synovial fluid.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/purpose: Subclinical inflammation linked to monosodium urate (MSU) crystals in gout and asymptomatic hyperuricemia (AH) remains poorly understood. We aimed to assess the cellular and inflammatory proteomic profiles in synovial fluid (SF) associated with MSU crystals, as observed by ultrasound or microscopy. Methods: 100 participants with AH or intercritical gout underwent clinical assessment, blood testing, musculoskeletal ultrasound, and SF aspiration. 81 samples were available for assessment. SF leukocyte counts and the inflammatory proteome from cell lysates were studied. Samples were compared based on ultrasound deposition (double-contour sign, tophi, or aggregates) and microcrystal deposition (MSU, CPP, no crystals). The analyses included protein expression comparisons, paired SF-serum correlations, and machine-learning predictive models development. Results: Leukocyte counts were higher in samples with MSU crystals [n=5] than in samples with CPP crystals [n=11] or no crystals [n=65]. A third of the MSU crystals were found intracellularly. MSU-containing samples showed several inflammatory proteins upregulated, including OSM, ADA, MCP3, CXCL-1, CXCL-6, and TNFSF14. CXCL-1 was preponderant in the predictive models. Ultrasound deposits were not associated with differences in leukocytes or proteome expression. Pro-inflammatory chemokines showed direct relationships at paired SF-sera correlations. Conclusion: Despite its low prevalence in our sample, MSU crystal deposition was associated with subclinical inflammation characterized by elevated leukocyte counts and a distinctive inflammatory proteome in SF cells. Conversely, ultrasound deposits were not predictive of differences in SF inflammatory features. Most subclinical inflammation appears localized to the joint, but the parallel expression in the chemokine system requires further investigation to determine its relevance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.